Thymosin Alpha-1 for irAE Secondary to ICIs
Clinical trial NCT06178146 · UNKNOWN
Trial details
- NCT number
- NCT06178146
- Sponsor
- Jun Wang
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.